Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-19

Clinical Trial Update: Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. [Phase 3]

View source ↗

Summary

A Phase 3 trial in adult renal transplant patients compares everolimus with cyclosporine microemulsion versus everolimus with enteric-coated mycophenolate sodiu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enteric-coated Mycophenolate Sodium (EC-MPS) (mycophenolate sodium)
  • Everolimus (everolimus)
  • cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19